Duey Marc

SEC Form 4 insider trading activity

Duey Marc has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jun 17, 2026.

On the most recent filing, Duey Marc is listed as Director at Aprea Therapeutics, Inc. Inside the rolling window, Duey Marc reported 1 open-market purchase totaling $25K in APRE and no open-market sales.

Companies traded

Other insiders at APRE

Insider Buying

$25K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
APRE
Duey Marc
Purchase$25KDec 11SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Duey Marc made?

Duey Marc has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.

Which companies does Duey Marc trade?

Duey Marc has filed SEC Form 4 disclosures for 1 company, including APRE.

When was Duey Marc's most recent SEC Form 4 filing?

Duey Marc's most recent SEC Form 4 filing on Tracefour is dated Jun 17, 2026.

What is Duey Marc's total buy and sell value in the current window?

Inside the rolling retention window, Duey Marc bought $25K and sold $0 based on SEC Form 4 filings.

What was Duey Marc's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 21,459 APRE shares on 2025-12-10, worth $25K, per SEC Form 4 filings.